Cargando…
Cost‐Effectiveness of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease and Acute Coronary Syndromes in the US Medicare Program
BACKGROUND: Coronary revascularization provides important long‐term clinical benefits to patients with high‐risk presentations of coronary artery disease, including those with chronic kidney disease. The cost‐effectiveness of coronary interventions in this setting is not known. METHODS AND RESULTS:...
Autores principales: | Reynolds, Matthew R., Gong, Tingting, Li, Shuling, Herzog, Charles A., Charytan, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174359/ https://www.ncbi.nlm.nih.gov/pubmed/33787323 http://dx.doi.org/10.1161/JAHA.120.019391 |
Ejemplares similares
-
Risks of Death and Graft Failure After Surgical Versus Percutaneous Coronary Revascularization in Renal Transplant Patients
por: Charytan, David M., et al.
Publicado: (2013) -
Comparison of percutaneous coronary intervention of native coronary artery versus bypass graft in patients with prior coronary artery bypass grafting
por: Yang, Zhiqiang, et al.
Publicado: (2023) -
Coronary Artery Bypass Grafting Among Patients With Prior Percutaneous Coronary Interventions
por: Kahlon, Ravi S., et al.
Publicado: (2018) -
Factors associated with the rates of coronary artery bypass graft and percutaneous coronary intervention
por: Kim, Agnus M., et al.
Publicado: (2019) -
Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting
por: Kumar, Ratan, et al.
Publicado: (2020)